Porcupine 抑制剂 GNF6231 靶向 Wnt 信号改善实验性皮肤纤维化
该研究在四种系统性硬化症(SSc)小鼠模型中评估 Porcupine 抑制剂 GNF6231 的抗纤维化作用。结果显示,治疗剂量 GNF6231 抑制纤维化皮肤中 Wnt 信号激活,改善全部四种模型的皮肤纤维化,并减轻 cGvHD 相关肺纤维化。GNF6231 可阻止纤维化进展,并有逆转已建立纤维化的证据。
要点
- Porcupine 抑制剂 GNF6231 在四种 SSc 小鼠模型中均改善皮肤纤维化。
- GNF6231 抑制纤维化皮肤中 Wnt 信号激活,并减轻 cGvHD 相关肺纤维化。
- GNF6231 可阻止纤维化进展,并有逆转已建立纤维化的证据。
核心结论
- 靶向 Porcupine 抑制 Wnt 通路可能是治疗 SSc 纤维化的潜在方法。
- GNF6231 在四种 SSc 临床前模型中均显示抗纤维化效果。
研究设计与样本
- 在博来霉素诱导皮肤纤维化小鼠、tight-skin-1 小鼠、小鼠硬化性慢性移植物抗宿主病(cGvHD)模型及组成性激活 TGF-β 受体 I 诱导的纤维化模型中评估 GNF6231。
主要发现
- 药理学相关且耐受良好的剂量 GNF6231 抑制纤维化小鼠皮肤中 Wnt 信号激活。
- GNF6231 改善全部四种模型的皮肤纤维化。
- GNF6231 减轻小鼠 cGvHD 相关肺纤维化。
- GNF6231 阻止纤维化进展,并有逆转已建立纤维化的证据。
关键数值与推荐
- GNF6231 使用药理学相关且耐受良好的剂量。
- GNF6231 在四种 SSc 小鼠模型中均改善皮肤纤维化。
临床怎么用
- Porcupine 抑制为 SSc 纤维化提供潜在治疗靶点,GNF6231 的密切类似物已在人体显示强效通路抑制,可能可供临床试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Wnt signalling has been implicated in activating a fibrogenic programme in fibroblasts in systemic sclerosis (SSc). Porcupine is an O-acyltransferase required for secretion of Wnt proteins in mammals. Here, we aimed to evaluate the antifibrotic effects of pharmacological inhibition of porcupine in preclinical models of SSc. METHODS: The porcupine inhibitor GNF6231 was evaluated in the mouse models of bleomycin-induced skin fibrosis, in tight-skin-1 mice, in murine sclerodermatous chronic-graft-versus-host disease (cGvHD) and in fibrosis induced by a constitutively active transforming growth factor-β-receptor I. RESULTS: Treatment with pharmacologically relevant and well-tolerated doses of GNF6231 inhibited the activation of Wnt signalling in fibrotic murine skin. GNF6231 ameliorated skin fibrosis in all four models. Treatment with GNF6231 also reduced pulmonary fibrosis associated with murine cGvHD. Most importantly, GNF6231 prevented progression of fibrosis and showed evidence of reversal of established fibrosis. CONCLUSIONS: These data suggest that targeting the Wnt pathway through inhibition of porcupine provides a potential therapeutic approach to fibrosis in SSc. This is of particular interest, as a close analogue of GNF6231 has already demonstrated robust pathway inhibition in humans and could be available for clinical trials.
引用
- Chen CW, Beyer C, Liu J, et al. Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling. Ann Rheum Dis. 2017. PMID: 28153829. doi:10.1136/annrheumdis-2016-210294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。